Judge Rejects Ivax Challenges To Depomed Patents
U.S. District Judge Charles Breyer entered a Markman ruling in agreement with Depomed on two patents in the U.S. District Court for the Northern District of California on Wednesday.
The Menlo Park, Calif.-based company lodged the suit against Ivax back in January, alleging that Ivax’ extended-release metformin hydrochloride tablets infringe Depomed’s pair of patents. The patents deal with...
To view the full article, register now.